James “Jim” D. Watson, who helped discover the structure of DNA at age 25 and went on to spend 21 years as a Harvard biology ...

Every year, the Future Perfect team curates the undersung activists, organizers, and thinkers who are making the world a ...

Predictive indicators for whether a child will be vulnerable to certain diseases after birth, as well as their future height, ...

Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat ...

Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment ...

Despite treatment with standard-of-care anti-seizure medicines, children with Dravet syndrome experienced high seizure burden and plateaued in ...

For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy(R) and Ozempic(R) for only $199 each beginning November 17, 2025 -- Also effective November 17, ...

Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.